Topics
Low-grade gliomas | Treatment | Targeted therapy | Selumetinib
Home > Publications > Topics > Low-grade gliomas > Treatment > Targeted terapy > Selumetinib
Fangusaro J, Onar-Thomas A, Young
Poussaint T, Lensing S, Ligon AH, Lindeman N, Banerjee A, Kilburn
LB, Lenzen A, Pillay-Smiley N, Pollack IF, Robison NJ, Partap S,
Qaddoumi I, Landi D, Jones DTW, Stewart CF, Fouladi M, Dunkel IJ.
A
Phase 2 PBTC Study of Selumetinib for Recurrent/Progressive
Pediatric Low-Grade Glioma: Strata 2, 5, and 6 with Long-term
Outcomes on Strata 1, 3, and 4.
Neuro
Oncol. 2025 Apr
17:noaf065. doi:
10.1093/neuonc/noaf065. PMID:
40241281. Interventional
study˰ ˍ